Abstract:Objectives Detailed analysis targeting B cell subgroups was considered crucial in monitoring autoimmune diseases and treatment responses. Thus, precisely describing the phenotypes of B cell differentiation and their variation in primary Sjogren's syndrome (pSS) is particularly needed. Methods To characterize the proportions and absolute counts of B cell subsets, peripheral blood from 114 healthy adults of China (age range: 19-73 years) and 55 patients with pSS were performed by flow cytometry and CD19, CD20, CD24, CD27, CD38 and IgD were used as surface markers to identify B cell mature process. Age- and gender-stratified analyses were then carried out to improve the interpretation of B cell subsets. Results The assessments from healthy adults showed that the proportion of naive B cells presented a significant increase with age. A reversal trend was noted that the percentage of B10 decreased markedly with age. In addition, analysis based on gender showed that the relative percentage and number of naive B cells were higher in females than in males whereas the proportions of switched memory B cells and B10 cells were decreased in female. Patients with pSS exhibited a significant expansion in naive B cells and unswitched memory B cells, accompanied with decreased switched memory B cells and B10 cells, which were identified to be associated with autoantibody production. Conclusions Our study presented a reliable analysis by flow cytometry to cover the principal B cell subtypes. These different stages of B lymphocytes may have implications for evaluating the activation of pSS and other autoimmune diseases and treatment efficacy. KEY MESSAGES B cell subsets play a pivotal role in the pathogenesis of primary Sjogren's syndrome (pSS) and other autoimmune diseases. A practical and accurate flow cytometry method to profile B cell phenotypes in peripheral blood of healthy adults is especially essential. Additionally, we presented reliable reference ranges for B cell subsets in regards to the local population. Age- and gender-related analyses are available to better understand their influence in immune status and treatment outcome. The distribution of B-cell subsets is found substantially altered in patients with pSS, bringing novel avenues for pSS research in the future.

Function of B Cells in Patients with Primary Sj(o)gren's Syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sjogren's syndrome

Biomarkers for Primary Sjögren’s Syndrome

The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome

Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment

Primary Sj(o)gren's syndrome and helper T cells and their cytokines

Profiles of peripheral B cell subsets in a cohort of primary Sjögren's syndrome patients and their potential clinical significance

Expression of FcγRⅡb on peripheral B cells and its clinical significance in patients with primary Sj(o)gren's syndrome

Interaction of Human Salivary Gland Epithelial Cells with B Lymphocytes: Implications in the Pathogenesis of Sjögren’s Syndrome

Expression of B Lymphocyte Stimulator in the Renal Tissues of Patients with Primary Sj(o)gren Syndrome

Immune skew of follicular helper T cells and effector T cells in patients with Sjögren's syndrome

Immunobiology of T Cells in Sjögren’s Syndrome

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjogren's syndrome

Treatment progress of primary sj(o)gren's syndrome

Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren’s syndrome

Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren’s syndrome

Abnormal Epigenetic Regulations in the Immunocytes of Sjögren's Syndrome Patients and Therapeutic Potentials

Th1 and Th17 Cells with the Sj(o)gren's Syndrome

Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials